|
 |
 |
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
||||
|
Home > Research X-Server-Uuid: E2E48A14-EE5B-4280-A138-188440602EDD X-Server-Uuid: E2E48A14-EE5B-4280-A138-188440602EDD X-WSS-ID: 6A0386CA0MC72926-01-01 Approved-By: Rex Jones <rex.jones@RADIOLOGY.UCSF.EDU> Date: Wed, 11 Apr 2007 14:44:40 -0700 Reply-to: "Rex Jones" <rex.jones@radiology.ucsf.edu> Sender: "Radiology Dept. info on research matters" <RADFACULTY1@ITSSRV1.UCSF.EDU> Comments: RFC822 error: and ignored. From: "Rex Jones" <rex.jones@radiology.ucsf.edu> Subject: NCI Cancer Imaging Program Newsletter No. 92 Comments: To: Radiology Research <RADRESEARCH@itssrv1.ucsf.edu> To: RADFACULTY1@ITSSRV1.UCSF.EDU List-Help: List-Unsubscribe: List-Subscribe: List-Owner: X-WSS-ID: 6A0386DC0MC72979-01-01 From: Cancer Imaging Program National Cancer Institute April 2007 Electronic Newsletter No. 92 CIP Web Site: <http://imaging.cancer.gov/>http://imaging.cancer.gov/. Current Newsletter NIH BIOENGINEERING RESEARCH PARTNERSHIPS (BRP)(Multiple IC's)(R01) (PAR-07-352) Application Submission/Receipt Date(s): Standard dates apply Participating Institutes and Centers (ICs) of the NIH invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological or medical research problems. In the context of this program, a partnership is a multi-disciplinary research team that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. URL: <http://grants.nih.gov/grants/guide/pa-files/PAR-07-352.html>http://grants.nih.gov/grants/guide/pa-files/PAR-07-352.html AVON-NCI "PROGRESS FOR PATIENTS" (PFP) AWARDS FOR EARLY PHASE CLINICAL INTERVENTIONS AND BIOMARKERS IN BREAST CANCER (LIMITED COMPETITIVE SUPPLEMENTS [REVISIONS] FOR P30 CANCER CENTER SUPPORT GRANTS) (NCI, AVON FOUNDATION AND FNIH) (PAR-07-244) AVON-NCI "PROGRESS FOR PATIENTS" (PFP) AWARDS FOR EARLY PHASE CLINICAL INTERVENTIONS AND BIOMARKERS IN BREAST CANCER (LIMITED COMPETITIVE SUPPLEMENTS [REVISIONS] FOR P50 SPORE GRANTS) (NCI, AVON FOUNDATION AND FNIH) (PAR-07-245) Application Receipt/Submission Date(s): April 27, 2007; November 15, 2007 The awards are designed to support activities that could not have been anticipated until recently, thus minimizing delays in conducting novel and promising Phase I and II clinical trials and studies focusing on risk assessment or validation of biomarkers in human subjects. All NCI-designated Cancer Center investigators are eligible to apply, so long as the criteria in regard to project responsiveness are met. However, anticipated funding period of the Avon-NCI award should not extend beyond the end date of the 5-year parent P30 project period or the project period of subcontractor grants. URL (for P30 grants): <http://grants.nih.gov/grants/guide/pa-files/PAR-07-244.html>http://grants.nih.gov/grants/guide/pa-files/PAR-07-244.html URL (for P50 grants): <http://grants.nih.gov/grants/guide/pa-files/PAR-07-245.html>http://grants.nih.gov/grants/guide/pa-files/PAR-07-245.html INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD (U54) (ROADMAP)(RFA-RM-07-007) Application Receipt Date: October 24, 2008 The goal of the Institutional Clinical and Translational Science Award (CTSA) program is to transform the local, regional and national environment for clinical and translational science, thereby increasing the efficiency and speed of clinical and translational research. This transformation will be achieved by creating an academic home, which can be a center, department, or Institute (C/D/I), comprising faculty and programs that integrate clinical and translational science across multiple departments, schools, clinical and research institutes and hospitals. The C/D/I should provide clinical research resources including infrastructure and training to various disciplines in its institution (e.g., medicine, dentistry, nursing, pharmacy, public health, biostatistics, epidemiology, bioengineering) for the benefit of researchers, trainees, and research projects across multiple aspects of health promotion and disease prevention, pre-emption, and treatment studied by a wide range of NIH Institutes and Centers. URL: <http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-07-007.html>http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-07-007.html DEVELOPMENT OF ASSAYS FOR HIGH-THROUGHPUT DRUG SCREENING (NIDDK, NCI, NIAID, NIMH) (R01) (PA-07-320) Receipt/Submission Date(s): Multiple dates, see announcement. The goal of this FOA is to establish a stream of scientifically and technologically outstanding assays that can be automated for HTS at an NIH-funded (or other) facility. NCI: The NCI is especially interested in proposals related to cancer prevention, treatment or response to treatment using imaging agents, molecular markers, or biochemical pathways. Assays pertinent to the mission of NCI should be justified as relevant to cancer and may include any physiology, cell biology or developmental process with the goal of identifying molecules that either perturb the system (e.g., drugs for cancer prevention or treatment) or yield molecular information (e.g., imaging agents). URL: <http://grants.nih.gov/grants/guide/pa-files/PA-07-320.html>http://grants.nih.gov/grants/guide/pa-files/PA-07-320.html INNOVATIONS IN BIOMEDICAL COMPUTATIONAL SCIENCE AND TECHNOLOGY (MULTIPLE ICS)(R01) (PAR-07-344) Application Receipt/Submission Date(s): May 24, 2007; September 24, 2007; January 24, 2008; May 24, 2008; September 24, 2008, January 24, 2009 The NIH is interested in promoting research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. The Institutes and Centers of the NIH offer support through the current solicitation for fundamental research in biomedical information science and technology as well as for the development of new informatics, computational and mathematical tools and technologies. URL: <http://grants.nih.gov/grants/guide/pa-files/PAR-07-344.html>http://grants.nih.gov/grants/guide/pa-files/PAR-07-344.html Other Agencies NIST ADVANCED TECHNOLOGY PROGRAM (ATP)(2007-ATP-01) Proposal receipt date: May 21, 2007 NIST is soliciting proposals in all technology areas (Competition Number 2007-A) as well as four broad Crosscutting Areas of National Interest. Four broad Crosscutting Areas of National Interest for the 2007 Competition provide a framework that links a diversity of technical areas to broad-based economic and societal benefits that are important for technological competitiveness and are well-known priorities for the nation. The areas of interest are each multi-disciplinary technological areas that impact a multitude of industry sectors and applications, and represent technology frontiers with many high-technical risk challenges. They also represent areas where teaming among industry, universities, government labs, and regional centers of excellence is likely to be highly competitive due to the nature of the technical challenges and the potential for economic benefits. The four areas are: * Technologies for Advanced and Complex Systems (Competition 2007-B), * Challenges in Advanced Materials and Devices (Competition 2007-C), * 21st Century Manufacturing (Competition 2007-D), and * Nanotechnology (Competition 2007-E). URL: <http://www.atp.nist.gov/atp/apply.htm>http://www.atp.nist.gov/atp/apply.htm Announcements CONTINUATION OF THE EXTENSION OF THE NIH PILOT STUDY TO SHORTEN THE REVIEW CYCLE FOR NEW INVESTIGATOR R01 APPLICATIONS (NOT-OD-07-058) The pilot effort was begun in 2006, and extended in January 2007, to allow new investigators to have the option of rapidly submitting a resubmission/amended R01 application for consecutive review cycles, saving four months. The Center for Scientific Review is committed to continuing this pilot for the current study sections and to the extension to all new investigator R01 applications by the end of 2007. Forty-six study sections will be included for the May/June 2007 meetings. URL: <http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-058.html>http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-058.html ACMUI SEEKS NUCLEAR PHARMACIST The U.S. Nuclear Regulatory Commission is advertising for nominations for the position of nuclear pharmacist on the Advisory Committee on the Medical Uses of Isotopes. Nominations are due on or before May 29, 2007. URL: <http://interactive.snm.org/index.cfm?PageID=6058&RPID=10>http://interactive.snm.org/index.cfm?PageID=6058&RPID=10 GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at micad@ncbi.nlm.nih.gov. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication. URL: <http://micad.nih.gov/>http://micad.nih.gov URL: <http://bookshelf.ncbi.nlm.nih.gov/books/bookres.fcgi/micad/infoguest.html>http://bookshelf.ncbi.nlm.nih.gov/books/bookres.fcgi/micad/infoguest.html). RSNA CLINICAL TRIALS METHODOLOGY WORKSHOP, JANUARY 5-11, 2008, PHOENIX, AZ Application deadline: June 5, 2007 This intensive 6 ? workshop is intended for faculty members, fellows, and 4th year residents in radiology, nuclear medicine, and radiation oncology departments, with MD or PhD degrees. Applicants will be competitively selected. URL: <http://www.rsna.org/CT2008>http://www.rsna.org/CT2008 Meetings 17th International Symposium on Radiopharmaceutical Sciences April 30 - May 4, 2007, Aachen, Germany URL: <http://srs.snm.org/docs/AD-ISRS-Final.pdf>http://srs.snm.org/docs/AD-ISRS-Final.pdf International Symposium on Ultrasonic Imaging and Tissue Characterization May 16-18, 2007, Holiday Inn/Rosslyn Westpark Hotel, Arlington, Virginia URL: <http://uitc-symposium.org/announcement.htm>http://uitc-symposium.org/announcement.htm ISMRM 15th Scientific Meeting and Exhibition May 19 - 25, 2007, Berlin, Germany URL: <http://www.ismrm.org/07/index.htm>http://www.ismrm.org/07/index.htm Society of Nuclear Medicine 54th Annual Scientific Meeting June 2 - 6, 2007, Washington, DC URL: <http://interactive.snm.org/index.cfm?PageID=5584&RPID=4425>http://interactive.snm.org/index.cfm?PageID=5584&RPID=4425 Society for Imaging Informatics in Medicine (SIIM) June 7-10, 2007, Providence, RI URL: <http://www.siim2007.org/>http://www.siim2007.org/ Frontiers of Biomedical Imaging Science June 27-29 2007,Nashville, Tennessee URL: <http://guest.cvent.com/EVENTS/Info/Summary.aspx?e=32b402bf-5929-4482-8bcf-477a8dfc2b0d>http://guest.cvent.com/EVENTS/Info/Summary.aspx?e=32b402bf-5929-4482-8bcf-477a8dfc2b0d CARS 2007 Computer Assisted Radiology and Surgery -21st International Congress and Exhibition June 27 - 30, 2007, Bonn, Germany URL: <http://www.cars-int.org/>http://www.cars-int.org/ American Association of Physicists in Medicine (AAPM) - 49th Annual Meeting July 22-26, 2007, Minneapolis, MN URL: <http://www.aapm.org/meetings/07AM/>http://www.aapm.org/meetings/07AM/ Molecular Imaging Joint Conference of the Academy of Molecular Imaging and the Society for Molecular Imaging September 7 - 11, 2007, Providence, Rhode Island URL: <http://www.ami-imaging.org/>http://www.ami-imaging.org _________________________________________________________________________ The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions. If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail ( Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI 6130 Executive Boulevard - MSC-7412Bethesda, MD 20892-7412Tel: 301 496 9531Fax: 301 480 3507 -- Rex Jones Research Administrator Department of Radiology University of California, San Francisco 3333 California Street, Suite 375 San Francisco, CA 94143-0629 Tel: 415-502-8700 Fax: 415-502-7493 |
|
|
|
|
|
|
|
|
|
